These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20045866)

  • 1. Pitavastatin decreases the expression of endothelial lipase both in vitro and in vivo.
    Kojima Y; Ishida T; Sun L; Yasuda T; Toh R; Rikitake Y; Fukuda A; Kume N; Koshiyama H; Taniguchi A; Hirata K
    Cardiovasc Res; 2010 Jul; 87(2):385-93. PubMed ID: 20045866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
    Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
    Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitavastatin decreases tau levels via the inactivation of Rho/ROCK.
    Hamano T; Yen SH; Gendron T; Ko LW; Kuriyama M
    Neurobiol Aging; 2012 Oct; 33(10):2306-20. PubMed ID: 22133277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
    Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
    Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
    Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R
    Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of endothelial lipase and systemic HDL cholesterol levels by SREBPs and VEGF-A.
    Kivelä AM; Dijkstra MH; Heinonen SE; Gurzeler E; Jauhiainen S; Levonen AL; Ylä-Herttuala S
    Atherosclerosis; 2012 Dec; 225(2):335-40. PubMed ID: 23102786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
    Lee MH; Cho YS; Han YM
    Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene.
    Ota K; Suehiro T; Arii K; Ikeda Y; Kumon Y; Osaki F; Hashimoto K
    Metabolism; 2005 Feb; 54(2):142-50. PubMed ID: 15690306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitavastatin: an overview.
    Saito Y
    Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
    Li J; Jiang J; Yin H; Wang L; Tian R; Li H; Wang Z; Li D; Wang Y; Gui Y; Walsh MP; Zheng XL
    Hypertension; 2012 Jul; 60(1):145-53. PubMed ID: 22615115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
    da Silva PM
    Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.
    Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H;
    J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway.
    Song JX; Ren JY; Chen H
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):213-22. PubMed ID: 21052011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-C.
    Teramoto T
    Expert Opin Pharmacother; 2012 Apr; 13(6):859-65. PubMed ID: 22332608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High density lipoprotein cholesterol and apolipoprotein A-I are persistently elevated during long-term treatment with pitavastatin, a new HMG-CoA reductase inhibitor.
    Fukutomi T; Takeda Y; Suzuki S; Ito T; Joh T; Itoh M
    Int J Cardiol; 2010 Jun; 141(3):320-2. PubMed ID: 19138801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells.
    Narumiya H; Sasaki S; Kuwahara N; Irie H; Kusaba T; Kameyama H; Tamagaki K; Hatta T; Takeda K; Matsubara H
    Cardiovasc Res; 2004 Nov; 64(2):331-6. PubMed ID: 15485693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway.
    Saka M; Obata K; Ichihara S; Cheng XW; Kimata H; Noda A; Izawa H; Nagata K; Yokota M
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1164-71. PubMed ID: 17184496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.